Phenotyping of chronic obstructive pulmonary disease using the modified bhalla scoring system for high-resolution computed tomography

Canadian Respiratory Journal

Volumn 20, Issue 2, 2013, Pages 91-96

  Tulek, Baykal ^a,c   Kivrak, Ali Sami ^b   Ozbek, Seda ^b   Kanat, Fikret ^a   Suerdem, Mecit ^a  

^a Department of Chest Diseases ^*  (Turkey)

^b SELCUK UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; High resolution computed tomography; Phenotype

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BHALLA SCORING SYSTEM; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; DISEASE EXACERBATION; EMPHYSEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIROMETRY; SCORING SYSTEM;

EID: 84876271765     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/727523     Document Type: Article

References (37)

1. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053-61.
2. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-9.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: A systematic review and meta-analysis. Eur Respir J 2006;28:523-32.
4. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
5. Copley SJ, Wells AU, Muller NL, et al. Thin-section CT in obstructive pulmonary disease: Discriminatory value. Radiology 2002;223:812-9.
6. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006;100:1742-52.
7. Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest 2011;140:634-42.
8. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: Scoring system with thin-section CT. Radiology 1991;179:783-8.
9. Demirkazik FB, Ariyurek OM, Ozcelik U, Gocmen A, Hassanabad HK, Kiper N. High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 2001;37:54-9.
10. Judge EP, Dodd JD, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 2006;130:1424-32.
11. Global initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, Mangement, and Prevention of Chronic Obstructive Pulmonary Disease. (Accessed November 30, 2012).
12. Mets OM, de Jong PA, van Ginneken B, Gietema HA, Lammers JW. Quantitative computed tomography in COPD: Possibilities and limitations. Lung 2012;190:133-45.
13. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002;121(5 Suppl):151S-5S.
14. Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: Cellular and molecular mechanisms. Eur Respir J 2008;31:396-406.
15. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
16. Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132:1565-72.
17. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:400-7.
18. Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011;140:1130-7.
19. Yuan R, Hogg JC, Pare PD, et al. Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography. Thorax 2009;64:944-9.
20. O'Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004;59:837-42.
21. Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009;6:459-67.
22. Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: Correlation with low attenuation areas on CT. Thorax 2009;64:20-5.
23. Bon JM, Leader JK, Weissfeld JL, et al. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One 2009;4:e6865.
24. Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:940-5.
25. Coxson HO, Lam S. Quantitative assessment of the airway wall using computed tomography and optical coherence tomography. Proc Am Thorac Soc 2009;6:439-43.
26. Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-8.
27. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61:17-22.
28. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-53.
29. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250-5.
30. Marin A, Garcia-Aymerich J, Sauleda J, et al. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012;9:121-30.
31. Omori H, Tsuji M, Sata K, et al. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema. Respirology 2009;14:551-8.
32. O'Donnell AE. Bronchiectasis in patients with COPD: A distinct COPD phenotype? Chest 2011;140:1107-8.
33. Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: Associated radiologic phenotypes. Radiology 2011;261:274-82.
34. Nakano Y, Coxson HO, Bosan S, et al. Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med 2001;164:2195-9.
35. Flaherty KR, Kazerooni EA, Curtis JL, et al. Short-term and longterm outcomes after bilateral lung volume reduction surgery: Prediction by quantitative CT. Chest 2001;119:1337-46.
36. Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: An integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 2010;11:136.
37. Mets OM, Smit EJ, Mohamed Hoesein FA, et al. Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One 2012;7:e42227.